Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 5—May 2025
Research Letter

Clinical and Epidemiologic Characteristics of Mpox Cases, Dominican Republic, July 2022–February 2023

Robert Paulino-RamirezComments to Author , Wilfredo Rafael Matias, Hector Lora-Rodríguez, Grey Benoît, Joel Ureña, Monica Thormann, and Ronald Skewes-Ramm
Author affiliation: Universidad Iberoamericana, Santo Domingo, Dominican Republic (R. Paulino-Ramirez, H. Lora-Rodriguez); Brigham and Women's Hospital, Boston, Massachusetts, USA (W.R. Matias); Massachusetts General Hospital, Boston (W.R. Matias); Ministry of Health, Santo Domingo (G. Benoît, M. Thormann, R. Skewes-Ramm); Ministry of Defense, Santo Domingo (J. Ureña)

Main Article

Table

Clinical and epidemiologic characteristics of suspected mpox cases in the Dominican Republic, July 2022–February 2023*

Patient characteristics Confirmed cases Negative cases
Total
71 (100.0)
212 (100.0)
Sex
M 48 (67.6) 124 (58.5)
F
23 (32.4)
88 (41.5)
Age range, y
0–9 16 (22.5) 55 (25.9)
10–19 6 (8.5) 22 (10.4)
20–29 19 (26.8) 41 (19.3)
30–39 16 (22.5) 45 (21.2)
40–49 4 (5.6) 15 (7.1)
50–59 7 (9.9) 15 (7.1)
>60
3 (4.2)
19 (9.0)
Country of birth
Dominican Republic 68 (95.8) 202 (95.3)
Other†
3 (4.2)
10 (4.7)
Highest education level
None 10 (14.1) 38 (17.9)
Elementary school 8 (11.3) 23 (10.9)
Middle school 7 (9.9) 17 (8.0)
High school 14 (19.7) 47 (22.2)
College or technical school 11 (15.5) 24 (11.3)
Missing
21 (29.6)
63 (29.7)
Health region of residence
I Valdesia 13 (18.3) 19 (9.0)
II Cibao Norte 11 (15.5) 25 (11.8)
III Cibao Nordeste 0 11 (5.2)
IV Enriquillo 0 10 (4.7)
O Metropolitana 39 (54.9) 122 (57.5)
V Este 6 (8.5) 11 (5.2)
VI Del Valle 0 2 (0.9)
VII Cibao Occidental 1 (1.4) 9 (4.2)
VIII Cibao Central
1 (1.4)
3 (1.4)
Health insurance type
Private 23 (32.4) 55 (25.9)
Government subsidized 8 (11.3) 20 (9.4)
No reported insurance 11 (15.5) 53 (25.0)
Unknown
29 (40.8)
84 (39.6)
Time from symptom onset to seeking care, d (range)
5.0 (2.5–7.0)
4.0 (2.0–7.0)
Underlying illness
Chronic diseases‡ 5 (7.0) 8 (3.8)
HIV/AIDS 7 (9.9) 3 (1.4)
Malnutrition 0 (0.0) 2 (0.9)
Obesity/overweight 0 (0.0) 3 (1.4)
None 29 (40.8) 99 (46.7)
Missing 30 (42.3) 97 (45.8)

*Values are no. (%) except as indicated. †Includes Germany, Belgium, United States, Haiti, Italy, Democratic Republic of Congo, Switzerland, and Venezuela. ‡Includes diabetes, chronic respiratory disease, hypertension, or other cardiovascular disease.

Main Article

Page created: March 07, 2025
Page updated: March 17, 2025
Page reviewed: March 17, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external